Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EYENOVIA, INC.

(EYEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about EYENOVIA, INC.
09/17EYENOVIA : Arctic Vision Expand Licence Deal to Include Another Eye Drug
MT
09/17Arctic Vision Announces Addition of Novel Mydriatic Drug MydcombiÖ to Eyenovia Commerci..
CI
09/15EYENOVIA : Material Definitive Agreement (Form 8-K)
PU
09/15EYENOVIA, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
09/15Eyenovia, Inc. Enters into Amendment to Certain License Agreement with Arctic Vision (H..
CI
08/12EYENOVIA : Management's Discussion and Analysis of Financial Condition and Results of Oper..
AQ
08/11EYENOVIA : Announced positive topline data from its Phase 3 VISION-1 study evaluating Micr..
PU
08/11EYENOVIA, INC. : Results of Operations and Financial Condition, Other Events, Financial St..
AQ
08/11Eyenovia, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
08/11Eyenovia Reports Second Quarter 2021 Financial Results
GL
08/04Eyenovia to Report Second Quarter 2021 Results on Wednesday, August 11
GL
07/19EYENOVIA : to Participate in a Presbyopia Panel Discussion at Eyecelerator 2021
BU
07/07Eyenovia to Participate in Two Upcoming Investor Conferences
GL
06/21EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/16EYENOVIA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/16Declaration of Voting Results by Eyenovia, Inc
CI
06/15EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/15EYENOVIA : highlights Recent Progress in Three Phase 3 Programs, NDA Review Progress and L..
PU
06/15Eyenovia, Inc. Provides Corporate Update on Pipeline with Recent and Upcoming Milestone..
CI
06/15Eyenovia highlights Recent Progress in Three Phase 3 Programs, NDA Review Progress and ..
GL
06/10Stuart M. Grant Provides Information to shareholders of Eyenovia
CI
05/25EYENOVIA : Reports Positive Topline Results From Phase 3 Study of MicroLine to Treat Presb..
MT
05/25Eyenovia Announces Positive Topline Results from VISION-1 Phase 3 Clinical Study of Mic..
GL
05/25EYENOVIA : Announces Positive Topline Results from VISION-1 Phase 3 Clinical Study of Micr..
PU
05/25EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/25Eyenovia, Inc. Announces Positive Topline Data from Its Phase 3 Vision-1 Study
CI
05/14EYENOVIA, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhi..
AQ
05/14EYENOVIA : Management's Discussion and Analysis of Financial Condition and Results of Oper..
AQ
05/14EYENOVIA : Completed patient enrollment in Phase 3 VISION-1 study evaluating MicroLine for..
PU
05/12EYENOVIA, INC. : Results of Operations and Financial Condition, Financial Statements and E..
AQ
05/12Eyenovia, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
05/12Eyenovia Reports First Quarter 2021 Financial Results
GL
05/12EYENOVIA : Announces New $25 Million Credit Facility with Silicon Valley Bank (Form 8-K)
PU
05/10EYENOVIA, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financia..
AQ
05/10Eyenovia, Inc. Enters into Loan and Security Agreement
CI
05/10Eyenovia Announces New $25 Million Credit Facility with Silicon Valley Bank
GL
05/05EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/05Eyenovia to Report First Quarter 2021 Results on Wednesday, May 12
GL
04/20INSIDER TRENDS : Eyenovia Insider 90-Day Buying Trend Prolonged with Purchase
MT
04/01EYENOVIA : HC Wainwright Adjusts Price Target on Eyenovia to $8 From $6, Maintains Buy Rat..
MT
04/01EYENOVIA, INC. : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
04/01EYENOVIA : Announces Appointment of Renowned Ophthalmologist and Scientific Leader Dr. Jul..
BU
04/01Eyenovia Announces Appointment of Julia Haller to Its Board of Directors
CI
03/30EYENOVIA : Management's Discussion and Analysis of Financial Condition and Results of Oper..
AQ
03/25EYENOVIA, INC. : Results of Operations and Financial Condition, Financial Statements and E..
AQ
03/25EYENOVIA : Pares Q4 Loss, Posts Revenue
MT
03/25Eyenovia, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
CI
03/25Eyenovia Reports Fourth Quarter and Full Year 2020 Financial Results
GL
03/24EYENOVIA : and EVERSANA Announce Partnership to Support the Potential Launch and Commercia..
AQ
03/23EYENOVIA : Teams Up With Eversana to Commercialize MydCombi in US
MT
03/23EYENOVIA : and EVERSANA Announce Partnership to Support the Potential Launch and Commercia..
BU
03/23Eyenovia, Inc. and Eversana Announce Partnership to Support the Potential Launch and Co..
CI
03/18EYENOVIA : Announces Publication of MIST Pivotal Studies Demonstrating the Efficacy and Sa..
AQ
03/18EYENOVIA : to Report Fourth Quarter and Full Year 2020 Results on Thursday, March 25
AQ
03/17EYENOVIA : Announces Publication of MIST Pivotal Studies Demonstrating the Efficacy and Sa..
BU
03/17Eyenovia Announces Publication of MIST Pivotal Studies Demonstrating the Efficacy and S..
CI
03/15EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
03/10EYENOVIA : to Participate in the 33rd Annual Roth Conference
AQ
03/02EYENOVIA : Reports MydCombi New Drug Application Acceptance From US FDA
MT
03/02EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
03/02Eyenovia, Inc. Announces Fda Acceptance of the Mydcombi NDA
CI
03/02EYENOVIA : Announces FDA Acceptance of the MydCombi NDA
BU
03/01EYENOVIA : Northland Starts Eyenovia at Outperform With $10 Price Target
MT
02/16EYENOVIA : to Host Key Opinion Leader Webinar on Presbyopia
AQ
02/03EYENOVIA, INC. : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
02/03Eyenovia, Inc. Appoints Michael M. Rowe to Chief Operating Officer
CI
01/27EYENOVIA : to Present at the Ophthalmology Innovation Summit Presbyopia Innovation Showcas..
AQ
01/26EYENOVIA : to Present at the Ophthalmology Innovation Summit (OIS) Presbyopia Innovation S..
BU
01/06EYENOVIA : to Participate in Presbyopia Panel Discussion at the LifeSci Partners 10th Annu..
AQ
2020EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020EYENOVIA : Submits New Drug Application for Pupil Dilation Agent
MT
2020EYENOVIA : Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi T..
BU
2020Eyenovia, Inc. Submits New Drug Application to FDA for Pharmacologic Mydriasis with Myd..
CI
2020EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020EYENOVIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
1  2  3  4Next
Upcoming event on EYENOVIA, INC.